References
- Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 1986;4:379–408.
- Lerner UH. Regulation of bone metabolism by the kallikrein-kinin system, the coagulation cascade, and the acute-phase reactants. Oral Surg Oral Med Oral Pathol 1994;4:481–93.
- Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000;5484:1501–4.
- Katagiri T, Takahashi N. Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 2002;3:147–59.
- Zheng MH, Wood DJ, Papadimitriou JM. What's new in the role of cytokines on osteoblast proliferation and differentiation? Pathol Res Pract 1992;8:1104–21
- Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000;2:115–37.
- Frost A, Jonsson KB, Brandstrom H, Ljunghall S, Nilsson O, Ljunggren O. Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha. Bone 2001;3:268–74.
- Silfversward CJ, Frost A, Brandstrom H, Nilsson O, Ljunggren O. Interleukin-4 and interleukin-13 potentiate interleukin-1 induced secretion of interleukin-6 in human osteoblast-like cells. J Orthop Res 2004;5:1058–62.
- Lewis DB, Liggitt HD, Effmann EL, Motlay ST, Teitelbaum SL, Jepsen KJ, Goldstein SA, Bonadio J, Carpenter J, Perlmutter RM. Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci USA 1993;24:11618–22.
- Majeska RJ. Culture of osteoblastic cells. Bilezikian JP, Raisz LG, Rodan GA. Principles of bone biology. San Diego, CA: Academic Press, 1996.
- Stein GS, Lian JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993;4:424–42.
- Termine JD, Robey PG. Bone matrix proteins and the mineralization process. Favus MJ. Primer on the metabolic bone diseases and disorders of mineral metabolism, 3rd. Philadelphia, PA: Lippincott-Raven Publishers, 1996. 24–28.
- Malaval L, Liu F, Roche P, Aubin JE. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem 1999;4:616–27.
- Mundy GR, Boyce B, Hughes D, Wright K, Bonewald L, Dallas S, Harris S, Ghosh-Choudhury N, Chen D, Dunstan C. The effects of cytokines and growth factors on osteoblastic cells. Bone 1995;2(Suppl.):71S–75S.
- Riancho JA, Zarrabeitia MT, Olmos JM, Amado JA, Olmos JM, Gonzalez-Macias J. Effects of interleukin-4 on human osteoblast-like cells. Bone Miner 1993;1:53–61.
- Nohtomi K, Sato K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K. Stimulation of interleukin-4 of cell proliferation and mRNA expression of alkaline phosphatase and collagen type I in human osteoblast-like cells of trabecular bone. Bone Miner 1994;1:69–79.
- Ueno K, Katayama T, Miyamoto T, Koshihara Y. Interleukin-4 enhances in vitro mineralization in human osteoblast-like cells. Biochem Biophys Res Commun 1992;3: 1521–6.